Darvocet will be taken off the market.
This stems from confusion with recent news of the UK yanking Co-proxamol, an acetaminophen/dextropropoxyphene combination product...similar to Darvocet.
The UK's Committee on Safety of Medicines (CSM) says the benefits of Co-proxamol aren't worth the risks. It's linked to 300-400 fatal overdoses each year in the UK.
The CSM goes on to say that Co-proxamol doesn't seem to relieve pain any better than acetaminophen alone.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote